Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22879 | 365 | 25.9 | 45% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
535 | 3 | TAURINE//CHRONIC GRANULOMATOUS DISEASE//L FORMS | 19480 |
1301 | 2 | CHRONIC GRANULOMATOUS DISEASE//FORMYL PEPTIDE RECEPTOR//NADPH OXIDASE | 8571 |
22879 | 1 | BENZYDAMINE//1 BENZYL 1H INDAZOL 3 OL//ANTIBIOTICS COMBINATION WITH BENZYDAMINE | 365 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BENZYDAMINE | authKW | 282744 | 4% | 26% | 13 |
2 | 1 BENZYL 1H INDAZOL 3 OL | authKW | 83658 | 0% | 100% | 1 |
3 | ANTIBIOTICS COMBINATION WITH BENZYDAMINE | authKW | 83658 | 0% | 100% | 1 |
4 | ANTISEPTIC ANTIBIOTIC AGENT | authKW | 83658 | 0% | 100% | 1 |
5 | BENZYDAMINE BACTERICIDAL ACTIVITY COMBINATION WITH ANTIBIOTICS IN VITRO STUDIES | authKW | 83658 | 0% | 100% | 1 |
6 | BENZYDAMINE DOSAGE FORMS QUANTITATIVE DETERMINATION | authKW | 83658 | 0% | 100% | 1 |
7 | BENZYDAMINE POISONING | authKW | 83658 | 0% | 100% | 1 |
8 | CAS 642 72 8 | authKW | 83658 | 0% | 100% | 1 |
9 | CYCLOOXGENASE INHIBITORS | authKW | 83658 | 0% | 100% | 1 |
10 | DUNN CHAMBER | authKW | 83658 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2307 | 47% | 0% | 170 |
2 | Rheumatology | 1027 | 10% | 0% | 36 |
3 | Immunology | 359 | 16% | 0% | 60 |
4 | Medicine, Research & Experimental | 134 | 8% | 0% | 30 |
5 | Chemistry, Medicinal | 130 | 6% | 0% | 23 |
6 | Cell Biology | 75 | 9% | 0% | 34 |
7 | Allergy | 23 | 1% | 0% | 5 |
8 | Hematology | 19 | 3% | 0% | 11 |
9 | Chemistry, Multidisciplinary | 17 | 8% | 0% | 28 |
10 | Pathology | 10 | 2% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DUYGUDURUM BOZUKLUKLARI BIRIMI BASKANI KM PASA | 83658 | 0% | 100% | 1 |
2 | INTERNAL MEDCLIN TOXICOL UNIT | 83658 | 0% | 100% | 1 |
3 | MED GEN SISTEMAT 3 | 41828 | 0% | 50% | 1 |
4 | BIOCHIM PL BIOTECHNOL | 27885 | 0% | 33% | 1 |
5 | MED SURG 1 PHARMACOL TOXICOL | 27885 | 0% | 33% | 1 |
6 | OXYGEN DEV CORD | 27885 | 0% | 33% | 1 |
7 | SERV INFORMAC TOXICOL | 27885 | 0% | 33% | 1 |
8 | HLTH ISS | 20913 | 0% | 25% | 1 |
9 | POISON CONTROL MILAN | 20913 | 0% | 25% | 1 |
10 | S MIDORI KU | 20913 | 0% | 25% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AGENTS AND ACTIONS | 8429 | 5% | 1% | 18 |
2 | INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS | 7437 | 2% | 1% | 9 |
3 | INFLAMMATION | 7243 | 4% | 1% | 15 |
4 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 6151 | 5% | 0% | 18 |
5 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 4700 | 1% | 2% | 3 |
6 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 3408 | 4% | 0% | 14 |
7 | BIOCHEMICAL PHARMACOLOGY | 3040 | 7% | 0% | 26 |
8 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH | 1391 | 1% | 0% | 4 |
9 | FOLIA PHARMACOLOGICA JAPONICA | 1211 | 1% | 0% | 4 |
10 | BLOOD CELLS | 1125 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AYDIN, PC , OZGEN, G , CEKIC, M , (2014) BENZYDAMINE ABUSE IN A CASE WITH PSYCHOSIS RELATED TO MULTIPLE SUBSTANCE ABUSE.ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY. VOL. 15. ISSUE . P. S4-S6 | 5 | 83% | 0 |
2 | BALABAN, OD , ATAGUN, MI , YILMAZ, H , YAZAR, MS , ALPKAN, LR , (2013) BENZYDAMINE ABUSE AS A HALLUCINOGEN: A CASE REPORT.KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. VOL. 23. ISSUE 3. P. 276 -279 | 5 | 83% | 0 |
3 | CARLUCCI, G , IULIANI, P , DI FEDERICO, L , (2010) SIMULTANEOUS DETERMINATION OF BENZYDAMINE HYDROCHLORIDE AND FIVE IMPURITIES IN AN ORAL COLLUTORY AS A PHARMACEUTICAL FORMULATION BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.JOURNAL OF CHROMATOGRAPHIC SCIENCE. VOL. 48. ISSUE 10. P. 854-859 | 7 | 64% | 0 |
4 | PERIANIN, A , GAUDRY, M , MARQUETTY, C , GIROUD, JP , HAKIM, J , (1988) PROTECTIVE EFFECT OF INDOMETHACIN AGAINST CHEMOTACTIC DEACTIVATION OF HUMAN-NEUTROPHILS INDUCED BY FORMYLATED PEPTIDE.BIOCHEMICAL PHARMACOLOGY. VOL. 37. ISSUE 9. P. 1693-1698 | 14 | 70% | 4 |
5 | BAREGGI, SR , PEDRAZZINI, S , DEANGELIS, M , (1988) PHARMACOKINETIC STUDY IN MAN WITH THE NON-STEROIDAL ANTIINFLAMMATORY DRUG FLUNOXAPROFEN - SERUM CONCENTRATION-TIME PROFILE AFTER ORAL OR TOPICAL PREPARATIONS.ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. VOL. 38-1. ISSUE 4. P. 574-577 | 10 | 91% | 0 |
6 | LAROCHE, F , KAHAN, A , KAHAN, A , LETRAIT, M , COHEN, C , JAMIN, P , STRAUCH, G , (1994) KETOPROFEN AND PREDNISOLONE DO NOT MODULATE NEUTROPHIL CR-1, CR3 AND FC-GAMMA-RIII EXPRESSION IN HEALTHY-VOLUNTEERS.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 38. ISSUE 5. P. 441-445 | 11 | 58% | 2 |
7 | ANDREANI, A , GRANAIOLA, M , LEONI, A , LOCATELLI, A , MORIGI, R , RAMBALDI, M , RODA, A , GUARDIGLI, M , TRANIELLO, S , SPISANI, S , (2004) N-BENZYL-2-CHLOROINDOLE-3-CARBOXYLIC ACIDS AS POTENTIAL ANTI-INFLAMMATORY AGENTS. SYNTHESIS AND SCREENING FOR THE EFFECTS ON HUMAN NEUTROPHIL FUNCTIONS AND ON COX1/COX2 ACTIVITY.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 39. ISSUE 9. P. 785 -791 | 10 | 40% | 9 |
8 | WHITE, S , (1991) TOPICAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) IN THE TREATMENT OF INFLAMMATORY MUSCULOSKELETAL DISORDERS.PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. VOL. 43. ISSUE 4. P. 209-222 | 16 | 40% | 8 |
9 | CAPSONI, F , VENEGONI, E , MINONZIO, F , FORGIONE, A , ZANOBONI, A , ZANUSSI, C , (1986) EFFECT OF FLUNOXAPROFEN ON HUMAN PHAGOCYTIC CELL-FUNCTION.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 39. ISSUE 1. P. 75-81 | 9 | 90% | 4 |
10 | PERIANIN, A , GIROUD, JP , HAKIM, J , (1987) NONSTEROIDAL ANTIINFLAMMATORY DRUG AS TOOLS FOR ANALYSIS OF NEUTROPHIL FUNCTIONS.BIOMEDICINE & PHARMACOTHERAPY. VOL. 41. ISSUE 6. P. 315-321 | 9 | 82% | 5 |
Classes with closest relation at Level 1 |